New Pre-Surgery drug combo shows promise in slowing breast cancer growth
Knowledge-focused
Completed
This study tested whether adding a drug that targets specific genetic changes in breast tumors before surgery can slow tumor growth better than standard hormone therapy alone. It involved 19 women with ER-positive, HER2-negative breast cancer. The approach aims to personalize tre…
Phase: PHASE2 • Sponsor: Jennifer Lee Caswell-Jin • Aim: Knowledge-focused
Last updated May 26, 2026 10:29 UTC